Delivery Order SPE2DB22D1017-SPE2DB25FF8XY

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a firm fixed-price, with a ceiling value of $4,739.66 and a performance period through March 19, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Depakote DR 125 mg sprinkle capsules, with a potential value of $1,681.50 and a period of performance through January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceuticals and medical supplies to support military treatment programs and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.03 firm fixed-price contract is for the supply of Depakote DR 125 mg sprinkle capsules, a medication used to treat certain types of seizures. The contract has an ultimate completion date of October 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,383.36 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. This contract is for the delivery of 4,563,172,594 units of the prescription medication Depakote DR 250 mg tablets. The contract has a completion date of December 26, 2023 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.18 firm fixed-price delivery order contract is for the supply of Depakote DR 125 mg sprinkle capsules, a medication used to treat various medical conditions. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA). The contract, valued at $5,963.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 5, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,164.33 firm fixed-price delivery order is for the supply of Depakote DR 125 mg sprinkle capsules to support military treatment facilities and federal healthcare programs. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a federal contract award valued at $1,170.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of divalproex delayed-release capsules. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of November 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $1,276.08. The contract is for the delivery of Depakote ER 250 mg tablets, a medication used to treat certain types of seizures and mental health conditions. The contract is a firm fixed-price, delivery order type with a period of performance ending on November 13, 2024. This award is not associated with a set-aside program....
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,831.25, is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of February 18, 2025 and was awarded on February 17, 2025. This delivery order is associated with a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF8XY
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,326.61, is for the delivery of 4,567,750 units of Depakote DR 125 mg sprinkle capsules to support military healthcare programs. The contract has an ultimate completion date of April 1, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/1/25, 8:12 AM